Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Neurogastroenterol Motil. 2012 May;24(5):432-7, e210. doi: 10.1111/j.1365-2982.2011.01873.x. Epub 2012 Jan 25.
Up to 50% of the patients suspected of reflux laryngitis syndrome failed to respond to acid suppression therapy. However, predictors of acid suppression success have not been determined.
Consecutive patients with chronic laryngitis were enrolled prospectively. All the patients underwent laryngoscopy, esophagogastroduodenoscopy and 24-h multichannel intraluminal impedance and pH (MII-pH) monitoring before receiving rabeprazole 10 mg b.i.d. for 3 months. Patient was considered as a responder to acid suppression if the chief laryngeal complaint score during the last week since last interview had decreased by at least 50% after the start of therapy compared with baseline. Cox regression analysis was used to determine the independent predictors of acid suppression success.
Of 92 patients (age 42.4 ± 14.3 years, 50 women), 42 (45.7%) responded to acid suppression after 3 months. Gastroesophageal reflux disease was defined in 22 patients, of whom 19 patients had pathological distal esophageal acid exposure and 5 were defined as erosive esophagitis. The time to response showed a significant hazard ratio for patients with increased distal esophageal acid exposure time (β: 0.93; HR: 2.55; 95% CI: 1.24-5.24; P = 0.011) and increased laryngopharyngeal bolus exposure time (BET; β: 0.96; HR: 2.61; 95% CI: 1.36-5.00; P = 0.004). The latter had the best Youden Index (0.34) and accuracy (68.5%).
CONCLUSIONS & INFERENCES: The success of acid suppression on chronic laryngitis could be predicted using reflux parameters detected by MII-pH, among which increased laryngopharyngeal BET is the best.
多达 50%怀疑患有反流性喉炎综合征的患者对抑酸治疗无反应。然而,尚未确定抑酸治疗成功的预测因素。
连续招募慢性喉炎患者。所有患者在接受雷贝拉唑 10mg,bid,治疗 3 个月前,均行喉镜检查、食管胃十二指肠镜检查和 24 小时多通道腔内阻抗-pH(MII-pH)监测。如果在最后一次访谈后的最后一周,患者的主要喉部主诉评分与基线相比下降至少 50%,则认为患者对抑酸治疗有反应。采用 Cox 回归分析确定抑酸治疗成功的独立预测因素。
92 例患者(年龄 42.4±14.3 岁,50 例女性),3 个月后有 42 例(45.7%)对抑酸治疗有反应。22 例患者被诊断为胃食管反流病,其中 19 例患者存在病理性远端食管酸暴露,5 例被诊断为糜烂性食管炎。反应时间对远端食管酸暴露时间增加(β:0.93;HR:2.55;95%CI:1.24-5.24;P=0.011)和咽喉反流物暴露时间(BET)增加(β:0.96;HR:2.61;95%CI:1.36-5.00;P=0.004)的患者具有显著的危险比。后者具有最佳的约登指数(0.34)和准确性(68.5%)。
使用 MII-pH 检测到的反流参数可以预测慢性喉炎的抑酸治疗效果,其中咽喉反流物 BET 增加是最佳预测因素。